By focusing on chromatin-modifying enzymes, viral proteins, and noncoding RNAs, the researchers hope to uncover new pathways for a functional cure for chronic hepatitis B. The review highlights the ...
Bepirovirsen demonstrated a statistically significant functional cure rate vs placebo in participants with baseline HBsAg less than or equal to 3000 IU/mL. Topline data were announced from two phase 3 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Durham company is making ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Arbutus, which last year trimmed ...
Background and aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in chronic hepatitis B. To optimize PEG-IFN administration, this ...
With a $416,000 grant from the National Institutes of Health (NIH), SLU scientists will continue work to cure hepatitis B, building on significant findings published in two recent papers. John Tavis, ...
Patients infected with hepatitis C have had the ability to rid their livers of the virus for some time, while patients with chronic hepatitis B virus infection have been required to take medications ...
The UAB Mary Heersink Institute for Global Health and the UAB Department of Medicine, Division of Infectious Diseases, hosted a seminar on Thursday, Aug. 29, featuring guest speaker Michael Vinikoor, ...
New Delhi: According to the World Health Organization (WHO), viral hepatitis has now become as deadly as tuberculosis. Every 30 seconds, someone in the world dies of viral hepatitis. The WHO’s 2024 ...